Rhythm Pharmaceuticals (RYTM) Times Interest Earned (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Times Interest Earned of -$11.43 for Q1 2026, down 31.47% year-over-year from -$16.67 in Q1 2025, and down 12.03% quarter-over-quarter from -$10.2 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Times Interest Earned (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Times Interest Earned for 11 consecutive years, with -$11.43 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned fell 31.47% year-over-year to -$11.43; the TTM figure through Mar 2026 stood at -$9.99 (down 16.98% YoY), while the FY2025 annual figure was -$0.5, up 38.24% from the prior year.
- Times Interest Earned slipped to -$11.43 in Q1 2026 per RYTM's latest filing, from -$10.2 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$7.43 in Q3 2024 and bottomed at -$29.42 in Q1 2024.
- Historically, Times Interest Earned has averaged -$13.0 across 5 years, with a median of -$11.43 in 2026.
- Annual changes were most pronounced in 2024 — Times Interest Earned plunged 71.43% — and 2025, when it surged 70.46%.
- Rhythm Pharmaceuticals' Times Interest Earned stood at -$13.98 in 2022, then jumped by 35.14% to -$9.07 in 2023, then advanced by 16.49% to -$7.57 in 2024, then slumped by 34.64% to -$10.2 in 2025, then retreated by 12.03% to -$11.43 in 2026.
- Business Quant data shows RYTM's Times Interest Earned at -$11.43 in Q1 2026, -$10.2 in Q4 2025, and -$11.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | -10.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.69 |
| Mar 31, 2026 | -11.43 |
| Dec 31, 2025 | -10.20 |
| Sep 30, 2025 | -11.10 |
| Jun 30, 2025 | -7.79 |
| Mar 31, 2025 | -8.69 |
| Dec 31, 2024 | -7.57 |
| Sep 30, 2024 | -7.43 |
| Jun 30, 2024 | -8.79 |
| Mar 31, 2024 | -29.42 |
| Dec 31, 2023 | -9.07 |
| Sep 30, 2023 | -13.37 |
| Jun 30, 2023 | -14.11 |
| Mar 31, 2023 | -17.16 |
| Dec 31, 2022 | -13.98 |
| Sep 30, 2022 | -14.75 |
| Jun 30, 2022 | -17.35 |
| Mar 31, 2022 | -18.80 |
| Dec 31, 2021 | -15.86 |
| Sep 30, 2021 | -13.79 |